| Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry E Michalkiewicz, R Sandrini, B Figueiredo, ECM Miranda, E Caran, ... Journal of clinical oncology 22 (5), 838-845, 2004 | 571 | 2004 |
| A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies AC Vigorito, WM Azevedo, JFC Marques, AM Azevedo, KAB Eid, ... Bone marrow transplantation 22 (12), 1145-1151, 1998 | 235 | 1998 |
| Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation JEL Visentainer, SR Lieber, LBL Persoli, AC Vigorito, FJP Aranha, ... Experimental hematology 31 (11), 1044-1050, 2003 | 130 | 2003 |
| Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia R Bizzetto, C Bonfim, V Rocha, G Socié, F Locatelli, KW Chan, O Ramirez, ... haematologica 96 (1), 134, 2011 | 106 | 2011 |
| Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT CC Boer, MEP Correa, ECM Miranda, CA De Souza Bone marrow transplantation 45 (4), 705-711, 2010 | 88 | 2010 |
| Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation JFA Noronha, CA De Souza, AC Vigorito, FJP Aranha, R Zulli, ... Clinical & Laboratory Haematology 25 (1), 47-54, 2003 | 86 | 2003 |
| Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression‐free survival in multiple myeloma A Maiolino, VTM Hungria, M Garnica, G Oliveira‐Duarte, LCO Oliveira, ... American journal of hematology 87 (10), 948-952, 2012 | 82 | 2012 |
| Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire JS Castro, IB Selegatto, RS Castro, ECM Miranda, JPC de Vasconcelos, ... Scientific reports 8 (1), 2076, 2018 | 69 | 2018 |
| The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the … GJ Ruiz-Argüelles, D Gomez-Almaguer, A Morales-Toquero, ... Bone marrow transplantation 36 (12), 1043-1047, 2005 | 59 | 2005 |
| Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco … AM Carella, CA De Souza, S Luminari, L Marcheselli, A Chiappella, ... Leukemia & lymphoma 54 (1), 53-57, 2013 | 53 | 2013 |
| IL2 and TNFA Gene Polymorphisms and the Risk of Graft‐versus‐Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation DO Viel, LT Tsuneto, CR Sossai, SR Lieber, SBD Marques, AC Vigorito, ... Scandinavian journal of immunology 66 (6), 703-710, 2007 | 52 | 2007 |
| Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population JEL Visentainer, SR Lieber, LBL Persoli, SBD Marques, AC Vigorito, ... Cytokine 32 (3-4), 171-177, 2005 | 51 | 2005 |
| A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update AC Vigorito, JFM Junior, FJ Aranha, GB Oliveira, EC Miranda, ... Haematologica 86 (6), 665-666, 2001 | 44 | 2001 |
| Influence of BCR-ABL transcript type on outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib KBB Pagnano, EC Miranda, MT Delamain, GO Duarte, EV de Paula, ... Clinical Lymphoma Myeloma and Leukemia 17 (11), 728-733, 2017 | 41 | 2017 |
| Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation DC Dieamant, SHA Bonon, RMB Peres, CRC Costa, DM Albuquerque, ... BMC infectious diseases 13, 1-8, 2013 | 41 | 2013 |
| Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience KBB Pagnano, F Traina, T Takahashi, GB Oliveira, MS Rossini, ... São Paulo Medical Journal 118, 173-178, 2000 | 37 | 2000 |
| Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma MES Takahashi, C Mosci, EM Souza, SQ Brunetto, E Etchebehere, ... Scientific reports 9 (1), 16429, 2019 | 32 | 2019 |
| Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors MJ Mastellaro, AL Seidinger, G Kang, R Abrahão, ECM Miranda, ... Cancer 123 (16), 3150-3158, 2017 | 31 | 2017 |
| Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin’s … RC Baldissera, M Nucci, AC Vigorito, A Maiolino, BP Simões, ... Acta haematologica 115 (1-2), 15-21, 2006 | 28 | 2006 |
| Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors-a single center … BF Ribeiro, ECM Miranda, DM Albuquerque, MT Delamain, ... Clinics 70 (8), 550-555, 2015 | 26 | 2015 |
